Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Oprelvekin-associated bilateral optic disk edema.

Daniel C Peterson1, David J Inwards, Brian R Younge

  • 1Department of Ophthalmology, Mayo Clinic, Rochester, Minnesota 55905, USA.

American Journal of Ophthalmology
|March 1, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Day 100 Absolute Monocyte/Lymphocyte Prognostic Score and Survival Post Autologous Peripheral Blood Hematopoietic Stem Cell Transplantation in Diffuse Large B-Cell Lymphoma.

Journal of cancer therapy·2025
Same author

Autologous Stem Cell Transplant in Fit Patients With Late Relapsed Diffuse Large B-Cell Lymphoma That Responded to Salvage Chemotherapy.

Transplantation and cellular therapy·2024
Same author

Randomized study of induction with bendamustine-rituximab ± bortezomib and maintenance with rituximab ± lenalidomide for MCL.

Blood·2024
Same author

Autologous stem cell transplant in fit patients with refractory or early relapsed diffuse large B-cell lymphoma that responded to salvage chemotherapy.

Haematologica·2024
Same author

Patterns of progression after immune checkpoint inhibitors for Hodgkin lymphoma: implications for radiation therapy.

Blood advances·2024
Same author

COVID-19 outcome is not affected by anti-CD20 or high-titer convalescent plasma in immunosuppressed patients.

Scientific reports·2023
Same journal

Reply to Comment on Visual Field Progression in Glaucoma Patients with Delayed Follow-Up.

American journal of ophthalmology·2026
Same journal

Comment on: "Safety and efficiency reducing retinopathy of prematurity guideline sensitivity: an external validation using a large US-based dataset".

American journal of ophthalmology·2026
Same journal

Reply to Comment on "Clinicopathological and Imaging Distinction Between Ocular Adnexal MALT Lymphoma and IgG4-Related Ophthalmic Disease".

American journal of ophthalmology·2026
Same journal

Comment on: Visual Field Progression in Glaucoma Patients With Delayed Follow-Up.

American journal of ophthalmology·2026
Same journal

Corneal sensitivity changes and nerve plexus abnormalities in noninfectious anterior uveitis.

American journal of ophthalmology·2026
Same journal

Role of Menopausal Hormone Therapy on Strabismus, Strabismus Surgery, and Reoperation Rates.

American journal of ophthalmology·2026
See all related articles

Oprelvekin therapy for thrombocytopenia may cause bilateral optic disk edema. This vision complication resolved after discontinuing the medication, indicating a potential link.

Area of Science:

  • Ophthalmology
  • Oncology
  • Pharmacology

Background:

  • Radioimmunotherapy is used for relapsed non-Hodgkins follicular lymphoma.
  • Thrombocytopenia is a common side effect requiring treatment.
  • Oprelvekin is a medication used to treat thrombocytopenia.

Observation:

  • A 38-year-old male patient experienced bilateral vision loss.
  • The patient was undergoing oprelvekin therapy for thrombocytopenia.
  • Funduscopic examination revealed bilateral optic disk edema.

Findings:

  • Magnetic resonance imaging of the brain and orbits was normal.
  • Lumbar puncture results were also normal.
  • Optic disk edema resolved upon cessation of oprelvekin therapy.

Related Experiment Videos

Implications:

  • Oprelvekin therapy may be associated with bilateral optic disk edema.
  • This adverse effect appears to be reversible.
  • Further investigation into oprelvekin-induced ocular toxicity is warranted.